- Home
- TLSI vs UHG Comparison
TLSI vs UHG Comparison
Compare TLSI & UHG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TLSI
- UHG
- Stock Information
- Founded
- TLSI 2010
- UHG 2004
- Country
- TLSI United States
- UHG United States
- Employees
- TLSI N/A
- UHG N/A
- Industry
- TLSI Medical Specialities
- UHG Homebuilding
- Sector
- TLSI Health Care
- UHG Consumer Discretionary
- Exchange
- TLSI Nasdaq
- UHG Nasdaq
- Market Cap
- TLSI 244.3M
- UHG 248.7M
- IPO Year
- TLSI N/A
- UHG N/A
- Fundamental
- Price
- TLSI $4.73
- UHG $4.02
- Analyst Decision
- TLSI Strong Buy
- UHG
- Analyst Count
- TLSI 4
- UHG 0
- Target Price
- TLSI $11.13
- UHG N/A
- AVG Volume (30 Days)
- TLSI 118.6K
- UHG 82.5K
- Earning Date
- TLSI 11-13-2025
- UHG 11-07-2025
- Dividend Yield
- TLSI N/A
- UHG N/A
- EPS Growth
- TLSI N/A
- UHG N/A
- EPS
- TLSI N/A
- UHG 0.10
- Revenue
- TLSI $35,990,000.00
- UHG $445,963,017.00
- Revenue This Year
- TLSI $56.79
- UHG N/A
- Revenue Next Year
- TLSI $54.15
- UHG N/A
- P/E Ratio
- TLSI N/A
- UHG $43.75
- Revenue Growth
- TLSI 45.50
- UHG 7.51
- 52 Week Low
- TLSI $3.42
- UHG $1.60
- 52 Week High
- TLSI $5.88
- UHG $6.93
- Technical
- Relative Strength Index (RSI)
- TLSI 48.36
- UHG 46.18
- Support Level
- TLSI $4.42
- UHG $3.82
- Resistance Level
- TLSI $4.67
- UHG $4.23
- Average True Range (ATR)
- TLSI 0.23
- UHG 0.26
- MACD
- TLSI -0.03
- UHG -0.02
- Stochastic Oscillator
- TLSI 61.87
- UHG 27.78
About TLSI TriSalus Life Sciences Inc.
TriSalus Life Sciences Inc is engaged in the research, development, and sales of drug delivery technology and immune-oncology therapeutics to improve outcomes in difficult-to-treat liver and pancreatic cancer. It is developing and marketing two product linesPressure Enabled Drug Delivery (PEDD) infusion systems, in use today, and an investigational agent, nelitolimod (SD-101), which shows potential to enhance immune system response in the treatment of hepatocellular cancer, pancreatic cancer and other liver solid tumors. TriNav is the newest therapy delivery device with SmartValve technology for the proprietary PEDD approach.
About UHG United Homes Group Inc
United Homes Group Inc operates as a homebuilder which operates with a land-light idea in the Southeast. The company currently has a presence in South Carolina, North Carolina, and Georgia and focuses on providing high-quality, affordable homes for the entry-level and first-move-up segments. The company has three reportable segments: GSH South Carolina, Rosewood, and Other.